Healthcare - Biotechnology - NASDAQ - US
$ 8.23
-2.72 %
$ 301 M
Market Cap
-2.9
P/E
BALANCE SHEET
668 M
ASSETS
92.4 M
LIABILITIES
575 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
iTeos Therapeutics, Inc.
| Current Assets | 551 M |
| Cash & Short-Term Investments | 532 M |
| Receivables | 6.5 M |
| Other Current Assets | 12.2 M |
| Non-Current Assets | 117 M |
| Long-Term Investments | 101 M |
| PP&E | 10.7 M |
| Other Non-Current Assets | 5.66 M |
| Current Liabilities | 40 M |
| Accounts Payable | 11.3 M |
| Short-Term Debt | 2.5 M |
| Other Current Liabilities | 26.2 M |
| Non-Current Liabilities | 52.3 M |
| Long-Term Debt | 4.81 M |
| Other Non-Current Liabilities | 47.5 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 251.2 | 284.8 | 848.5 | 336.3 | 19.9 | 22.0 |
| Short Term Investments | 280.7 | 328.4 | 0 | 0 | 0 | 0 |
| Receivables | 6.5 | 2.4 | 12.1 | 0.3 | 5.3 | 1.2 |
| Inventory | 0 | 0 | (10.1) | (0.3) | 0 | 0 |
| Other Current Assets | 12.2 | 12.7 | 14.1 | 2.9 | 0.9 | 0.5 |
| Total Current Assets | 550.7 | 628.3 | 874.7 | 339.5 | 26.1 | 23.7 |
| PP&E | 10.7 | 6.8 | 7.4 | 1.4 | 1.3 | 1.2 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 100.5 | 118.2 | 0.3 | 0.1 | 0.1 | 66 K |
| Other Long Term Assets | 5.7 | 1.7 | 2.3 | 3.5 | 3.2 | 2.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 667.6 | 755.0 | 884.7 | 344.6 | 30.7 | 27.4 |
| LIABILITIES | ||||||
| Accounts Payable | 11.3 | 7.7 | 5.1 | 3.0 | 1.2 | 1.4 |
| Short Term Debt | 2.5 | 1.7 | 1.5 | 0 | 0 | 0 |
| Other Current Liabilities | 17.8 | 30.7 | 21.3 | 7.5 | 9.7 | 3.3 |
| Total Current Liabilities | 40.0 | 42.0 | 304.1 | 15.0 | 13.2 | 5.0 |
| Long Term Debt | 4.8 | 3.8 | 4.6 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 47.5 | 45.8 | 23.2 | 6.4 | 1.9 | 7.3 |
| Total Liabilities | 92.4 | 91.7 | 331.9 | 21.4 | 15.1 | 12.3 |
| EQUITY | ||||||
| Common Stock | 36 K | 36 K | 35 K | 35 K | 1 K | 87 K |
| Retained Earnings | 124.6 | 237.3 | 140.6 | (73.9) | (35.9) | (10.8) |
| Other Accumulative Comprehensive Income/Loss | (13.2) | (9.6) | (1.0) | 0.6 | (0.2) | 11 K |
| Total Equity | 575.2 | 663.3 | 552.8 | 323.2 | 15.7 | 15.1 |
| Total Liabilities and Equity | 667.6 | 755.0 | 884.7 | 344.6 | 30.7 | 27.4 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 35.8 | 35.6 | 35.2 | 35.0 | 35.0 | 7.5 |